Latest Commonwealth Bank of Australia (ASX:CBA) News

The week’s biggest finance moves came from capital structure changes, fresh funding and one very large private asset revaluation. Governance fights and merger work also kept investors busy.

Commonwealth Bank of Australia has announced fully franked quarterly distributions ranging from AUD 1.2733 to AUD 1.3174 on four series of its PERLS capital notes, payable in September 2026.

Capital raising news drove the biggest swings in finance stocks this week, with SPC Global collapsing after a deeply discounted offer and Klevo Rewards jumping on fast payment growth. Deal approvals, buybacks and dividend updates kept the rest of the sector busy, but investors stayed selective.

Commonwealth Bank of Australia reported a steady cash profit of around $2.7 billion in 3Q26, balancing disciplined lending growth and cautious provisioning amid geopolitical and economic uncertainties.

Gold exposure was sold hard, while a lender and a legal-finance group caught steady buying. Dividends, buy-backs and new bank-style hybrids did the heavy lifting for sentiment.

Commonwealth Bank of Australia has updated its 2026 interim dividend details, confirming a fully franked payout of AUD 2.35 per share and setting the Dividend Reinvestment Plan price at AUD 174.47 with no discount.

Payments and lending names wore the biggest swings as investors reacted to a large placement, a takeover repricing, and a governance brawl. Deal terms, disclosure quality, and access to funding mattered more than “big picture” talk this week.

Commonwealth Bank of Australia announces a fully franked quarterly distribution of AUD 1.2657 per security for its PERLS XII capital notes, payable mid-June 2026.

A dividend shock, a mega-merger and a fresh equity raise dominated ASX finance names this week. Magellan surged on its Barrenjoey plan, while Excelsior plunged despite confirming a large special payout.

Commonwealth Bank of Australia has updated its interim dividend details, confirming a fully franked payout of AUD 2.35 per share with multi-currency payment options and a Dividend Reinvestment Plan participation of 13.5%.

The week was split between big earnings reactions and small-cap rocks-and-rigs rallies. Pro Medicus sank despite record numbers, while a handful of explorers jumped on fresh discoveries and policy wins.

Takeover chatter lit up Pepper Money, while Identitii ran hard after a regulator stepped in. At the other end, AMP slid despite higher profit, as investors weighed leadership change and legal costs.